Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer

Completed · Phase 1

Conditions studied: Advanced Solid Tumors, Neoplasms

In brief

The purpose of this study is to test how rifampin affects the removal of BMS-247550 (ixabepilone) from the body.

Key facts

Study ID

NCT00207090

Run by

R-Pharm

People needed

19

Starts

2005-09-01

Expected to finish

2008-11-01

Last updated by the study team

2020-11-02

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Up to three prior chemotherapy regimens
• Measurable or non-measurable disease
• Available for treatment and follow-up

You may not qualify if…

• Neuropathy
• Uncontrolled cardiovascular disease
• Refusal to participate in genetic analysis

Where it is running

• The Cleveland Clinic Foundation — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.